Major Medical Groups Urge States to Use Juul Settlement for Anti-Smoking Programs

Sep.29.2022
Major Medical Groups Urge States to Use Juul Settlement for Anti-Smoking Programs
Health groups urge states to use $438.5 million Juul settlement for tobacco prevention programs, especially for youth.

Major medical organizations are urging the state, which won a $438.5 million settlement against e-cigarette manufacturer Juul Labs Inc. earlier this month, to use the money towards tobacco prevention and cessation programs, particularly for young people.


Selling electronic cigarette products to children is illegal in all 50 states. However, since Juul released its sweet-flavored electronic cigarettes in 2017, there has been an increase in teenage use of nicotine-containing products. States and school districts have launched various educational campaigns aimed at discouraging children from using harmful and addictive products.


On September 6th, a settlement agreement was reached that not only requires Juul to pay fees to each state over the course of 6-10 years, but also prohibits the company from conducting any further marketing campaigns targeting young people. The agreement also restricts the range of product sales and advertising, prohibits the use of unapproved flavors by the US Food and Drug Administration, and prohibits the marketing of free samples and branded goods.


In a letter dated September 27, the Campaign for Tobacco-Free Kids, the American Cancer Society Cancer Action Network, the American Heart Association, the American Lung Association, and Americans for Nonsmokers' Rights and Truth Initiative have called on states to "build on the historic 1998 Master Settlement Agreement (MSA) with the tobacco industry, while avoiding some of the mistakes that were made, to achieve further success.


These organizations cited a report from the Smoke-Free Kids campaign, which showed that only 2.7% of the $27 billion in tobacco settlements and taxes collected by states in the 2022 fiscal year were allocated towards programs aimed at preventing children from smoking and assisting smokers in quitting.


Connecticut Attorney General William Tong stated in his announcement of the proposed settlement, expected to be finalized in October, that JUUL's flippant advertising campaigns have created a new generation of nicotine addicts. "They shamelessly marketed their e-cigarette products to minors, manipulated their chemical makeup to make them palatable to inexperienced users, utilized inadequate age verification procedures, and misled consumers about the nicotine content and addictiveness of their products," Tong wrote.


In a statement, Juul has said that the settlement agreement is "an important component of our ongoing efforts to address past issues.


It further stated, "The terms of this agreement are consistent with our current business practices implemented company-wide after being reset in the fall of 2019.


According to data from the Centers for Disease Control and Prevention, over two million high school students reported using e-cigarettes in 2021, with eight out of ten students using flavored products.


In 2019, Governor Gretchen Whitmer made Michigan the first state to ban flavored e-cigarette products in an effort to reduce youth vaping. Other states have also issued similar orders, and all states have incorporated e-cigarettes into laws that restrict the sale of tobacco to minors. At least 18 states have raised the legal smoking age to 21.


In 2020, the FDA banned all nicotine products flavors except for menthol and tobacco.


During the announcement of the settlement agreement, several state attorneys general stated their intention to use the funds for smoking cessation and prevention programs. Health organizations urged all states in a letter to "translate this admirable intention into a strong commitment expressed in the final text of the agreement.


In 2020, the Attorneys General of Connecticut, Oregon, and Texas began investigating the company's marketing and sales practices, with 30 other states joining the effort: Alabama, Arkansas, Delaware, Georgia, Hawaii, Idaho, Indiana, Kansas, Kentucky, Maryland, Maine, Mississippi, Montana, North Dakota, Nebraska, New Hampshire, New Jersey, Nevada, Ohio, Oklahoma, Rhode Island, South Carolina, South Dakota, Tennessee, Utah, Virginia, Vermont, Wisconsin, and Wyoming.


Afterward, the state of Maine chose to withdraw from the settlement.


Statement:


This article is compiled from third-party information and is provided solely for industry professionals to exchange and learn from.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot verify the truth or accuracy of the article's content. The compilation of this article is only intended for industry-related exchange and research.


Due to limitations in our translation abilities, the translated article may not fully reflect the original text. Please refer to the original text for accuracy.


In regards to any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions, 2FIRSTS maintains complete alignment with the Chinese government.


The ownership of the copyright for the compiled information belongs to the original media and authors. If there is any infringement, please contact us for the information to be deleted.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

FDA Authorizes 24 VELO Nicotine Pouches, Increasing U.S. Authorized Total by 56%
FDA Authorizes 24 VELO Nicotine Pouches, Increasing U.S. Authorized Total by 56%
The U.S. FDA authorized 24 VELO nicotine pouch products from a British American Tobacco subsidiary, raising the total number of authorized products from 43 to 67, a 55.8% increase. The newly authorized 4 mg products include lime and passion fruit flavors and feature certified child-resistant packaging. VELO's first FDA marketing authorization adds BAT to a list previously limited to PMI and Altria products, while bringing the agency's nicotine pouch review pilot total to 47 authorized products.
Oct.30
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives
Japan's Heated Tobacco Use Rises From 0.1% to 14.9% Over a Decade as Growth Extends Beyond Cigarette Switching
Japan's Heated Tobacco Use Rises From 0.1% to 14.9% Over a Decade as Growth Extends Beyond Cigarette Switching
A decade-long study published in The Lancet Regional Health – Western Pacific found that heated tobacco product use in Japan increased from 0.1% in 2015 to 14.9% in 2025, although growth slowed after 2018. Switching from conventional cigarettes remained an important source of HTP uptake, while the contribution from previously non-current users increased. Approximately 56% of HTP users also smoked conventional cigarettes in 2025. Separate industry data show that Japan's heated tobacco sales reached 73.4 billion units in fiscal 2025, approaching conventional cigarette sales of 78.2 billion units.
SCIENCE
Nov.10
South Korea Imports 12,126 Kg of Nicotine Analogues From April to August After Bringing Synthetic Nicotine Under Tobacco Law
South Korea Imports 12,126 Kg of Nicotine Analogues From April to August After Bringing Synthetic Nicotine Under Tobacco Law
South Korea's liquid-vape market is showing changes across raw-material imports, product types and sales channels after synthetic nicotine came under the Tobacco Business Act on April 24. Customs data show nicotine-analogue imports totaled 12,126 kilograms from April through August, while synthetic-nicotine imports over the same five months totaled 231,663 kilograms, just 39.3% of the amount imported in March alone. Physical liquid-vape stores tracked in Seoul and Gyeonggi Province fell 9.9%, unmanned outlets edged higher and online sales listings increased from 27,774 to 42,437. Government testing of 105 liquid inhalation products promoted as nicotine-free separately found nicotine in 13 and 6-methylnicotine in 12.
Sep.22
Juul Displays FDA-Authorized JUUL2, Highlights Age Verification at NACS Show 2026
Juul Displays FDA-Authorized JUUL2, Highlights Age Verification at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Juul Labs displayed its JUUL2 e-cigarette system alongside existing products, age-verification messaging and mobile coupons, 2Firsts observed. The JUUL2 device and Virginia Tobacco and Polar Menthol pods received FDA marketing authorization in August 2026. Booth materials highlighted longer battery life, greater e-liquid capacity and connected-device features. A TruAge sign and a mobile coupon presentation also featured at the booth, with weekly offers available to age-verified adult nicotine consumers at participating retailers.
EXPO
Oct.09
Why Does JPMorgan Favor BAT Over Philip Morris Despite Forecasting Slower Growth of 3.9% Versus 6.2%?
Why Does JPMorgan Favor BAT Over Philip Morris Despite Forecasting Slower Growth of 3.9% Versus 6.2%?
JPMorgan resumed equity research coverage of British American Tobacco (BAT), Philip Morris International (PMI) and Imperial Brands in November 2026, assigning BAT an Overweight rating and the other two companies Neutral ratings. The bank forecasts like-for-like sales growth of 3.9% for BAT and 6.2% for PMI in 2027, but estimates the two companies will trade at approximately 11 times and 21 times 2027 earnings, respectively. JPMorgan cited BAT's improving position in US nicotine pouches and vaping products as a driver of its investment outlook. BAT reported a 220% constant-currency increase in US modern oral nicotine revenue in the first half of 2026, while PMI's ZYN US shipments returned to growth in the third quarter. Imperial expects NGPs to represent 4% to 5% of sales and has expanded its oral portfolio through acquisitions.
Capital Markets
Nov.12